BLFS Collar Strategy
BLFS (BioLife Solutions, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals.
BLFS (BioLife Solutions, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $1.40B, a beta of 1.97 versus the broader market, a 52-week range of 17.86-29.81, average daily share volume of 639K, a public-listing history dating back to 1989, approximately 159 full-time employees. These structural characteristics shape how BLFS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.97 indicates BLFS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on BLFS?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current BLFS snapshot
As of June 30, 2026, spot at $27.88, ATM IV 78.50%, IV rank 19.10%, expected move 22.51%. The collar on BLFS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this collar structure on BLFS specifically: IV regime affects collar pricing on both sides; compressed BLFS IV at 78.50% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 22.51% (roughly $6.27 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BLFS expiries trade a higher absolute premium for lower per-day decay. Position sizing on BLFS should anchor to the underlying notional of $27.88 per share and to the trader's directional view on BLFS stock.
BLFS collar setup
The BLFS collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BLFS near $27.88, the first option leg uses a $29.27 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BLFS chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BLFS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $27.88 | long |
| Sell 1 | Call | $29.27 | N/A |
| Buy 1 | Put | $26.49 | N/A |
BLFS collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
BLFS collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on BLFS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on BLFS
Collars on BLFS hedge an existing long BLFS stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
BLFS thesis for this collar
The market-implied 1-standard-deviation range for BLFS extends from approximately $21.61 on the downside to $34.15 on the upside. A BLFS collar hedges an existing long BLFS position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current BLFS IV rank near 19.10% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BLFS at 78.50%. As a Healthcare name, BLFS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BLFS-specific events.
BLFS collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BLFS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BLFS alongside the broader basket even when BLFS-specific fundamentals are unchanged. Always rebuild the position from current BLFS chain quotes before placing a trade.
Frequently asked questions
- What is a collar on BLFS?
- A collar on BLFS is the collar strategy applied to BLFS (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With BLFS stock trading near $27.88, the strikes shown on this page are snapped to the nearest listed BLFS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are BLFS collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the BLFS collar priced from the end-of-day chain at a 30-day expiry (ATM IV 78.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BLFS collar?
- The breakeven for the BLFS collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BLFS market-implied 1-standard-deviation expected move is approximately 22.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on BLFS?
- Collars on BLFS hedge an existing long BLFS stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current BLFS implied volatility affect this collar?
- BLFS ATM IV is at 78.50% with IV rank near 19.10%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.